As cancer care professionals who experience the challenges of providing quality cancer care first-hand, NCOA members are well positioned to educate decision-makers on how coverage and reimbursement issues affect community oncology. State and federal legislation can have a significant impact on the financial viability of local cancer programs, which is why it's so important that our members make their voices heard.
In an effort to provide resources needed to effectively advocate on the issues that are important to them, our redesigned advocacy webpage features weekly legislation updates from the North Carolina General Assembly, local news, and more.
We want to hear from you! If there is a specific piece of legislation you want to know more about, an important resource we're missing, or if you want to get more involved, please contact us!
NCOA Joins Coalition Letter Urging Addition of the Cures 2.0 Concept Paper Title IV Provisions in the Next COVID-19 Relief Package
The North Carolina Oncology Association (NCOA) joined in a coalition letter to congressional leadership urging that Congress include the 21st Century Cures 2.0 concept paper, recently released by Representatives Diana DeGette and Fred Upton in upcoming legislation to further address the COVID-19 public health crisis. Specifically the letter urges leadership to include policy to provide Medicaid coverage of the routine care costs of clinical trials participation for patients with life-threatening conditions in every state. This critical protection is championed by Representatives Ben Ray Luján and Gus Bilirakis in the Clinical Treatment Act (H.R. 913).
ACCC members were invited to join legal experts and their ACCC colleagues for a one-hour overview and discussion about the Centers for Medicare & Medicaid Services (CMS) final CY 2020 OPPS and PFS rules. The webinar covered key proposals the agency has finalized under the OPPS that will affect next year’s payments for 340B hospitals, excepted off-campus provider-based departments (PBDs), as well as updates to the administration's pricing transparency and drug pricing reform efforts. A recording of this webinar, presentation slides, and rule summaries are available to ACCC members.
ACCC members can access summaries of the final rules here. [Requires Login] Also available, a summary of selected provisions of the CY2020 Hospital Price Transparency Requirements for Hospitals to Make Standard Charges Public final rule. [Requires Login]
View On-Demand Webinar Replay (Requires Login)